Press release
Acute Kidney Injury Clinical Trials | A Drug Pipeline Analysis Report 2024 | GUARD THERAPEUTICS, Rénibus Therapeutics
DelveInsight's 'Acute Kidney Injury Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Acute Kidney Injury therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Acute Kidney Injury pipeline domain.Key Takeaways from the Acute Kidney Injury Pipeline Report
Over 30+ Acute Kidney Injury pipeline therapies are in various stages of development, and their anticipated acceptance in the Acute Kidney Injury market would significantly increase market revenue.
Leading Acute Kidney Injury companies developing novel drug candidates to improve the Acute Kidney Injury treatment landscape include GUARD THERAPEUTICS, Rénibus Therapeutics, and others.
Promising Acute Kidney Injury pipeline therapies in various stages of development include RMC-035, RBT-1, and others.
Request for a sample report @ https://www.delveinsight.com/report-store/acute-kidney-injury-aki-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Acute Kidney Injury Overview
Acute Kidney Injury (AKI) is a sudden and often severe decline in kidney function that occurs over a short period of time, typically within hours to days. It is characterized by a rapid increase in serum creatinine levels and/or a decrease in urine output. AKI can result from various causes and may range from mild to severe, potentially leading to serious complications if not managed promptly.
Causes of Acute Kidney Injury
AKI can be caused by a wide range of factors, which are generally classified into three categories based on the location of the injury:
1. Pre-Renal Causes: Conditions that lead to reduced blood flow to the kidneys, causing decreased kidney perfusion.
- Hypovolemia: Dehydration, bleeding, or fluid loss.
- Decreased Cardiac Output: Heart failure, myocardial infarction.
- Vascular Issues: Renal artery stenosis or thrombosis.
2. Intrinsic Renal Causes: Direct damage to the kidney tissues.
- Acute Tubular Necrosis (ATN): Often due to ischemia or nephrotoxins (e.g., certain medications, contrast dyes).
- Acute Glomerulonephritis: Inflammation of the glomeruli.
- Acute Interstitial Nephritis: Inflammation of the kidney interstitium, often due to allergic reactions to medications.
3. Post-Renal Causes: Obstructions in the urinary tract that impede urine flow from the kidneys.
- Urinary Tract Obstruction: Kidney stones, tumors, or an enlarged prostate.
- Bladder Outlet Obstruction: Difficulty in urine passing through the bladder.
Signs and Symptoms
Symptoms of AKI can vary depending on the underlying cause and severity of the condition. Common signs and symptoms include:
- Reduced Urine Output: Less frequent urination or very low urine volume.
- Swelling: Fluid retention causing swelling in the legs, ankles, or face.
- Fatigue: Feeling unusually tired or weak.
- Shortness of Breath: Due to fluid buildup in the lungs.
- Nausea and Vomiting: Gastrointestinal symptoms.
- Confusion: Changes in mental status or consciousness.
- High Blood Pressure: Elevated blood pressure.
- Itching: Skin itching due to accumulation of toxins.
Diagnosis
Diagnosing AKI involves a combination of clinical evaluation, laboratory tests, and imaging studies:
1. Clinical Evaluation:
- Medical History: Assessing risk factors, medications, and recent illnesses.
- Physical Examination: Checking for signs of fluid overload, swelling, and other symptoms.
2. Laboratory Tests:
- Serum Creatinine: Elevated levels indicate impaired kidney function.
- Blood Urea Nitrogen (BUN): Increased levels can also suggest kidney dysfunction.
- Electrolytes: Imbalances in sodium, potassium, and other electrolytes.
- Urinalysis: Detects abnormalities in urine composition, such as protein, blood, or casts.
3. Imaging Studies:
- Ultrasound: To assess kidney size, shape, and potential obstructions.
- CT Scan: Helps in identifying structural abnormalities, such as stones or tumors.
- MRI: Used in some cases for detailed imaging.
4. Additional Tests:
- Kidney Biopsy: May be performed if there is a need to determine the specific type of kidney injury.
Treatment Options
Treatment for AKI aims to address the underlying cause, support kidney function, and manage complications:
1. Pre-Renal AKI:
- Fluid Resuscitation: Administer intravenous fluids to restore blood volume and improve perfusion.
- Medications: Treat underlying conditions like heart failure or sepsis.
2. Intrinsic Renal AKI:
- Discontinue Nephrotoxins: Stop any medications or substances that may be causing damage.
- Treat Underlying Conditions: Manage conditions like glomerulonephritis or interstitial nephritis with appropriate medications.
- Supportive Care: Include monitoring and managing fluid and electrolyte balance.
3. Post-Renal AKI:
- Relieve Obstruction: Address the cause of the obstruction, such as removing kidney stones, treating an enlarged prostate, or placing a urinary catheter.
4. Supportive Care:
- Dialysis: In cases of severe AKI where kidney function is critically impaired, dialysis may be required to remove toxins and excess fluids.
- Nutritional Support: Dietary modifications to manage electrolyte and fluid balance.
- Monitoring and Follow-Up: Regular monitoring of kidney function and adjusting treatment as necessary.
Prognosis and Follow-Up
The prognosis of AKI depends on the cause, severity, and timeliness of treatment. With prompt and appropriate management, many individuals recover fully. However, some may experience long-term kidney damage or progress to chronic kidney disease. Regular follow-up is crucial to monitor kidney function and adjust treatment as needed.
Acute Kidney Injury is a serious condition that requires prompt diagnosis and intervention. Understanding its causes, symptoms, and treatment options is essential for effective management and improving patient outcomes.
To know more about Acute Kidney Injury pipeline segment, visit: https://www.delveinsight.com/report-store/acute-kidney-injury-aki-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Acute Kidney Injury Pipeline Analysis: Drug Profile
RMC-035: GUARD THERAPEUTICS
Guard Therapeutics is developing RMC-035 (ROSgard), a biological drug candidate that utilizes one of the body's most powerful and universal protections against oxidative stress. RMC-035 is naturally designed to "target" the kidneys, allowing RMC-035 to be present when the kidneys are attacked by oxidative stress. Treatment with RMC-035 has the potential to save lives and prevent the risk of both acute and chronic kidney damage with subsequent serious consequences due to impaired kidney function, such as life-sustaining dialysis treatment. Currently, it is in Phase II stage of clinical trial evaluation to treat Acute Kidney Injury.
Discover more about the emerging Acute Kidney Injury drugs @ https://www.delveinsight.com/sample-request/acute-kidney-injury-aki-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Acute Kidney Injury Key Companies
GUARD THERAPEUTICS
Rénibus Therapeutics
Acute Kidney Injury Pipeline Therapies
RMC-035
RBT-1
Acute Kidney Injury Pipeline Therapeutics Assessment
By development stage
By product type
By route of administration
By molecule type
By MOA type
Scope of the Acute Kidney Injury Pipeline Report
Coverage: Global
Key Acute Kidney Injury Companies: GUARD THERAPEUTICS, Rénibus Therapeutics, and others
Key Acute Kidney Injury Pipeline Therapies: GS 248, Treprostinil, and others
Find out more about the Acute Kidney Injury treatment options in development @ https://www.delveinsight.com/sample-request/acute-kidney-injury-aki-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Table of Contents
1. Introduction
2. Executive Summary
3. Overview
4. Pipeline Therapeutics
5. Late-Stage Products (Phase III)
6. Mid-Stage Products (Phase II)
7. Early Stage Products (Phase I/II)
8. Preclinical Stage Products
9. Discovery Stage Products
10. Therapeutic Assessment
11. Inactive Products
12. Collaborations Assessment- Licensing / Partnering / Funding
13. Unmet Needs
14. Market Drivers and Barriers
15. Appendix
16. About DelveInsight
Trending Reports By DelveInsight:
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market
Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market
Contact Us
Kritika Rehani
info@delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Kidney Injury Clinical Trials | A Drug Pipeline Analysis Report 2024 | GUARD THERAPEUTICS, Rénibus Therapeutics here
News-ID: 3768515 • Views: …
More Releases from DelveInsight Business Research LLP

Personal Care Contract Manufacturing Market Forecast Report 2032: Competitive La …
DelveInsight's Personal Care Contract Manufacturing Market Insights Report 2032 provides the current and forecast market analysis, individual leading Personal Care Contract Manufacturing Companies market shares, challenges, Personal Care Contract Manufacturing Market Drivers, barriers, trends, and key market Personal Care Contract Manufacturing companies in the market.
To read more about the latest highlights related to the Personal Care Contract Manufacturing Market, get a snapshot of the key highlights entailed in the Market…

Burn Market Size Report 2032: Revenue Growth, Market Share, Companies and Opport …
DelveInsight's Burn Market Insights Report 2032 provides the current and forecast market analysis, individual leading Burn Companies market shares, challenges, Burn Market Drivers, barriers, trends, and key market Burn companies in the market.
To read more about the latest highlights related to the Burn Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/burn-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Burn Market Report
• The Burn market was valued at…

Global Automatic Mechanical Cardiopulmonary Resuscitation Devices Market Outlook …
DelveInsight's Automatic Mechanical Cardiopulmonary Resuscitation Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Automatic Mechanical Cardiopulmonary Resuscitation Devices Companies market shares, challenges, Automatic Mechanical Cardiopulmonary Resuscitation Devices Market Drivers, barriers, trends, and key market Automatic Mechanical Cardiopulmonary Resuscitation Devices companies in the market.
To read more about the latest highlights related to the Automatic Mechanical Cardiopulmonary Resuscitation Devices Market, get a snapshot of the key…

Gastrointestinal Anastomosis Market Size Report 2032: Emerging Technologies, App …
DelveInsight's Gastrointestinal Anastomosis Market Insights Report 2032 provides the current and forecast market analysis, individual leading Gastrointestinal Anastomosis Companies market shares, challenges, Gastrointestinal Anastomosis Market Drivers, barriers, trends, and key market Gastrointestinal Anastomosis companies in the market.
To read more about the latest highlights related to the Gastrointestinal Anastomosis Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/gastrointestinal-anastomosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Gastrointestinal Anastomosis Market…
More Releases for Acute
Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,…
Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market
Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but…
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H …
ReportsWorldwide has announced the addition of a new report title Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to…
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth…